603882 金域医学
2025/06 - 中期
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额350,469906,3481,230,8211,947,8432,087,971
投资活动产生之现金流量净额(199,328)(455,529)(634,534)(848,369)(1,009,618)
筹资活动产生之现金流量净额(401,359)(488,801)(1,062,016)(868,567)(53,033)
汇率变动对现金及现金等价物的影响(7,028)10,8327,38738,949(11,458)
现金及现金等价物净增加/(减少)(257,245)(27,150)(458,343)269,8561,013,862
期初现金及现金等价物余额2,422,5252,449,6742,908,0172,638,1611,624,300
期末现金及现金等价物余额2,165,2792,422,5252,449,6742,908,0172,638,161